✦ LIBER ✦

Reversal of the non-competitive behaviour of the angiotensin II-antagonist Sar1Ile8-AII by a nonpeptide AII-antagonist in vitro and in vivo

✍ Scribed by W. Wienen; W. Diederen; A.B.M. Mauz; J.C.A. van Meel

Book ID: 115886474
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 94 KB
Volume: 183
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(90)94715-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C43 - Pressor response to angiotensin II

C43 - Pressor response to angiotensin II in sodium replete normal subjects and its blockade by the angiotensin II (AII) antagonist SR 47436 (BMS 186295)

✍ J Ribstein; J Sissmann; A Picard; A Mimran 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

Effects of losartan, a nonpeptide angiot

Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats

✍ Kenji Mizuno; Makio Tani; Shigeatsu Hashimoto; Susumu Niimura; Hironobu Sanada; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Blockade of the pre- and postjunctional

Blockade of the pre- and postjunctional effects of angiotensin in vivo with a non-peptide angiotensin receptor antagonist

✍ Edwin K. Jackson; Tadashi Inagami 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 656 KB

In vitro and in vivo effects of UP 269-6

In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation

✍ A. Virone-Oddos; V. Desangle; D. Provost; M. Cazes; F. Caussade; A. Cloarec 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 828 KB

In vitro glucuronidation of the angioten

In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species

✍ T EBNER; G SCHÄNZLE; W WEBER; U SENT; J ELLIOTT 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

The pharmacokinetics and metabolism of D

The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs

✍ Y. N. Wong; K. A. Holm; D. L. Burcham; S.-M. Huang; C. Y. Quon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

DuP 532, 2-propy1-4-pentafluoroethyl-l-[ [2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylJ imidazole-5-carboxylic acid, is an orally active, non-peptide angiotensin I1 (AII) receptor antagonist. DuP 532 is more potent and longer acting than losartan, another A11 receptor antagonist currently undergoing ph